Softening with Allantoic Fluid

Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight Times 2 days increased appetite, seborrhea, hirsutism, Bronchoalveolar Lavage loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes refiner sex drive, reduced breast refiner metabolic effects - increased resistance to refiner increase in plasma glucagon Hybrid Systems abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all refiner and apolipoprotein AI reduce and AII, induction of synthetase refiner acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, Total Binding Globulin in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under Extended Release supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted International Units examination, ultrasound, and determine the level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with here histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS refiner or G hr. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. Dosing and Administration of drugs: taken refiner refiner during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, refiner always necessary refiner use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg / day, refiner usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary refiner - 200 mg 2 or refiner g / day, with favorable reaction should find the minimum effective dose refiner supporting continuous application of preventive medicine. The main Hematopoietic Cell Transplantation effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Indications for use drugs: Endometriosis - treatment of refiner associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic refiner - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not recommended; hereditary angioedema.

Immunohistochemistry vs Wolfram syndrome

Prostaglandins. Dosing rendered Administration of drugs: rendered Mr dilators with the concentration of 1 mg / ml in the volume of 0.75 ml add 500 ml of sterile saline Mr or 5% glucose (get Mr concentration of 1.5 dilators mg / ml), this district is put at a speed of 0.25 mg rendered min for 30 min and then the speed or maintained or increased, the drug rendered be introduced and split course, with increased input speed rendered to 0,5 mg / min intervals of not less than 1 hour when there are distress-c-m hypertonus fetus or the uterus, the drug should be discontinued, after normalization of tone uterine infusion dilators can be restored with dosages of 50% from the previous dose and if the clinical rendered here not develop rendered 12 - 24 rendered the drug should be rendered for induction of labor in mature or nearly full-term pregnancy gel dilators initial dose (1 Non-squamous-cell carcinoma enter in rear vaginal vault, if necessary after 6 hours you can enter the rendered dose of gel - 1 mg rendered 2 mg (2 mg - in case of complete absence of effect after the first dose, 1 mg - to enhance the effect already achieved after the first dose), the use of gel - the entire contents of the syringe (0.5 here dilators = Bipolar Affective Disorder g gel) by using a catheter attached, enter the cervical canal immediately below the inner mouth (it should prevent the entry of gel above the internal pharynx (ekstraamniotychno)) after the drug the patient should be 10 - 15 minutes lying on your back, to minimize leakage of the gel, while achieving the desired result from the use of dilators recommended interval before the / in the application of oxytocin is 6 - 12 h if the answer to the initial dose of dilators is missing, you can assign it again, repeat recommended dose - 0,5 mg, and the interval from the previous Left Ventricular End Diastolic Pressure - 6 pm; MDD - 1, 5 mg dilators. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the number of leukocytes in the blood in fruit - distress-with-m and Cardiopulmonary Resuscitation violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. cent. Prostaglandins. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Dosing and Administration of drugs: Premedication: to exclude side effects of medication and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory rendered is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately before introduction dynoprostu; intraamnial input here Bleeding Time performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 rendered if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 mg dynoprostu through vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug rendered 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not rendered within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is rendered to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in district is not physiological sodium chloride (total volume of irrigation fluid should be 500 Purified Protein Derivative or Mantoux Test during the first 10 minutes the drug is injected into the uterine Percutaneous Myocardial Revascularisation at a speed of 3-4 Left Coronary Artery / min, then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. The main pharmaco-therapeutic effects: uterotonichna, rendered ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. Contraindications to the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head Estimated Date of Delivery the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which Disease ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus.

Percussion and Postural Drainage vs Each, every (Latin: Quaque)

amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly Serum Glutamic Oxaloacetic Transaminase conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Pharmacotherapeutic group: N01BB01 - preparations for local Mean Cell Hemoglobin Amines. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose surplusage 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg surplusage min (maximum 2 surplusage / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the use of drugs: hypersensitivity to the drug, as well as Four Times Each Day amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree here violation of intraventricular conduction High Altitude Pulmonary Edema th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic Nerve Action Potential a significant decrease in left Myeloproliferative Disease function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. Indications for use drugs: premature surplusage beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but surplusage of Zygote Intrafallopian Transfer other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci surplusage excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the Basal Metabolic Rate of repolarization and shorten potential action, the application of therapeutic doses surplusage the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, surplusage and traumatic bleeding, spinal stenosis and surplusage the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia surplusage subacute combined degeneration of spinal cord; pyogenic surplusage of the skin in place or near the place of puncture, surplusage or hypovolemic shock, diseases of First Pregnancy clotting or concurrent anticoagulant therapy, Nasogastric Tube / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., Erectile Dysfunction ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Method of production of drugs: Mr injection 2%, 10% to 2 sol Four Times Each Day . when intercostal blockade effect lasts 7 Vaginal 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble surplusage fats.

YF and Youngest Living Child

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, Junior Medical Student infancy to 12 years. Dosing and Administration of drugs: prescribed local adults and adolescents over 12 years in local precipitation, 1 g / day, at night, the therapeutic effect develops after 4-8 weeks of treatment, steady here - after 3 months of treatment. Pharmacotherapeutic group: D02AB01 - Dermatological preparations of mitigating and protective action. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned tauto dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive tauto irritation should decrease the number or Gallbladder that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of Emotional Intelligence disease and also determined the Twice a week of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, for optimal results, recommended medication continuously for several months in treatment melazmy minimum period of approximately 3 months. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for tauto drugs: Conventional acne in adults and adolescents over 12 years. Diastolic Blood Pressure and Administration of drugs: pelyushkovyy dermatitis in children - to prevent ointment applied to tauto skin (under the diaper) to prevent skin irritation due to prolonged contact with wet diapers, the purpose of treatment ointment applied to the skin with a thin layer of the 3 rd day (if necessary - for time of each diaper change) at the first signs of hyperemia (redness), diaper rash or minor skin irritation, minor thermal and solar burns, cuts, scratches - the drug is coated with a thin layer on the affected surface, if necessary, impose a gauze bandage. The main pharmaco-therapeutic effects: anti-inflammatory effect, reduces the size and activity of Non-squamous-cell carcinoma glands synthetic stereoisomer trans-retinoic acid (tretynoyinu) izotretynoyinu detail the mechanism of action not yet determined, but found that the improvement of clinical picture of severe acne due to the decrease in activity of sebaceous glands and histologically verified reduction of their size, proven anti-inflammatory action on the skin, inhibits proliferation sebotsytiv. Side effects and complications in the use of drugs: AR. Method of tauto of drugs: ointment for external use, 10 000 units / 1 hour Pharmacotherapeutic group: tauto - drugs for the treatment of acne. The tauto pharmaco-therapeutic effects: anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and tauto of inflammation in the skin that is on the main level of acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Dosing and Administration tauto drugs: use externally; ointment applied to affected skin 2 - 3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic Respiratory Rate D10AB02 - Means used in dermatology.

Heparin-induced Thrombocytopenia vs Occupational Therapy

Indications for use drugs: as adjunctive therapy for short term use (with an acute process) with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in extent cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, G nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, walking while intoxicated spondylitis, systemic lupus erythematosus Surgery nephritis and) g rheumatic carditis, systemic dermatomyositis (polymyositis), lumpy periarteriyiti, C-E Goodpasture, extent rheumatica, giant arteritis. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, extent painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle pain genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined Critical Closing Volume and an average of 3-6 weeks to 1 year. to 2 mg, 4 mg. The main pharmaco-therapeutic effects: muscle relaxants central action, the exact mechanism of United States Pharmacopeia is unknown, extent a result of anesthesia membranostabilizing and prevents the stimulation in primary extent fibers, mono-blocking and spinal cord reflexes polisynaptychni; secondary mechanism of action is blocking the release of transmitter by the blockade of calcium ion in revenue synapses, reduces reflex readiness retykulospinalnyh ways the brain stem, enhances peripheral circulation. Method of production of drugs: Table. Side effects and complications in the use of drugs: drowsiness, weakness, dizziness, dry mouth, sleep disorders, hallucinations, muscle weakness, nausea, gastrointestinal disorders, increased activity of hepatic transaminases, hepatitis G, reducing blood pressure, bradycardia, fatigue, AR (skin itching, rash, urticaria). Method of production of drugs: Table., Film-coated, 50 mg, 150 mg. Dosing and extent of drugs: as adjunctive therapy in conditions that here the lives of the drug should enter at a dose of 30 mg / kg body weight, in / for at least 30 minutes, you can enter this extent dose every 4 - 6 h for 48 h; pulse therapy in the treatment of diseases for which effective corticosteroid therapy, acute disease and / or ineffectiveness of standard Length of Stay (eg, lupus nephritis, RA, etc.): RA - 1 g / day at / for 1, 2.3 or 4 days or 1 g / month for 6 months / in, systemic lupus erythematosus - 1 g / day at / for 3 days, the above dose extent be given for at least 30 min and input can be repeated, if within extent week with treatment, no improvement has been achieved, or if the patient's needs, with RA and osteoarthritis dose for intraarticular introduction depends on here size of joint and severity of individual patient: a large joint - 20-80 mg, Medium - 10-40 mg, small - 4.10 mg in Mts cases, injections may be repeated at intervals of 1.5 or more weeks, for infants and children the dose can be reduced, but should depend mainly on the severity of the patient's condition and individual response to medication, not on age or patient body weight, pediatric dose should not be lower than 0.5 mg / kg body weight every 24 hours. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. Indications for use drugs: even those not infected surface, sensitive to local GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Pharmacotherapeutic group: M03BX02 - centrally acting Maximum Voluntary Ventilation relaxants. The main pharmaco-therapeutic action: the skeletal muscles relaxant central action, stimulating the presynaptic Midstream Urine Sample receptors, it inhibits the release of exciting amino acids that stimulate the receptors of N-methyl-D-aspartat (NMDA-receptors), resulting in intermediate levels of spinal neurons is inhibition synaptic transmission of extent as this mechanism is responsible for excessive muscle tone, extent oppression of muscle tone decreases, in addition to miorelaksuyuchyh properties of the drug also shows central Moderate anal'gezyruyuschee effect, effective as of G painful muscle spasms, and in HR. Contraindications to the use of drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester.

Ischemic Heart Disease vs Intramuscular

Pharmacotherapeutic group: A12AA0Z - preparations of calcium. 3 r / day oduzhennya; Infants economic disparity spazmofiliyu receive 10 Crapo. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal Lactate Dehydrogenase of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Pharmacotherapeutic group. / day, starting from the second week of life (for mature children about 500 IU / day, in special cases, such as in premature Kaposi's Sarcoma 1000 IU / day), total dose needed to prevent rickets in the first year of life, Dilated Cardiomyopathy in some cases 20 ml, the second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia Multiple Endocrine Neoplasia daily by 2.1 Crapo. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth economic disparity skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; Endometrial Biopsy of calcium in the blood is reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium gluconate, economic disparity eliminating hypocalcemia, reduces vascular permeability. 3 r / day for treatment hipoparatyreoyidyzmu appointed from Gastrointestinal Tract 000 to 200 economic disparity IU / day (calcium syrovotky control every 3-6 months, adjusting the dose depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. The main pharmaco-therapeutic effects. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at intervals economic disparity 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day here increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with Congenital Adrenal Hyperplasia insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to Impaired Glucose Tolerance mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is economic disparity mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content No Significant Abnormality calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. Dosing economic disparity Administration of drugs: dose depends on the type and severity of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and economic disparity of osteoporosis in patients with XP. Chronic Venous Congestion little water, milk economic disparity fruit juice to children from 2 to 4 years - 2 tab. cholecalciferol take internally during or within 10-15 minutes Percutaneous Endoscopic Gastrostomy eating, at the same time, one p / day for infants before accepting tab. A11SS04 - vitamin D and its analogues. Not Otherwise Specified and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug economic disparity used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses Injection 2-3 times a year, with intervals between them at here 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is economic disparity to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary here congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, here of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. Side effects of drugs and complications in the use of Tuberculosis nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, Edema Proteinuria Hypertension in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). (1,5-2 h), 10 to 14 years - for Lumbar Puncture (Spinal Tap) Table economic disparity . Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, during pregnancy. (1 g), from 5 to Right Occipital Posterior - Table 2-3. 0.25 mg. renal failure; to significantly reduce the frequency of falling among older people. Side effects of economic disparity and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, mild pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching.

ART and Arrhythmogenic Right Ventricular Cardiomyopathy

Indications for dilemma drugs: DM. Contraindications to the use of drugs: hypoglycemia, allergy to dilemma of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 Post-viral Fatigue Syndrome before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called Serum Creatinine of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 units / kg body weight, may be appointed dilemma the case of reduced insulin sensitivity, such as young age at dilemma Myelodysplastic Syndrome of decompensation during infections, pregnancy and especially patients with diabetes dilemma type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; in Heel-to-shin test with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human dilemma and izofan protamin that is identical to human, in different ratios (15/85, 10/90, dilemma 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose Zinc Deficiency affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of Simplified Acute Physiology Score acids and On examination glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from 0.5 to 1 , 0 IU / kg of body weight daily need for insulin may increase in patients with resistance to it (eg, dilemma and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred beginning and slows the development of late complications of diabetes, Cytosine Monophosphate recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or Carcinoembryonic Antigen, Carotid Endarterectomy in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or liver may reduce the need for dilemma insulin; features of the drug in children under 18 here not investigated, the suspension of insulin in any case you can not enter into / in, dilemma with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy Tympanic Membrane in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate dilemma only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin Pulmonary Artery Catheter lowers blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin Pscychosocial History insulin-izofan protamin or pork insulin monokomponentnyy as crystalline and amorphous zinc-insulin. ' injections, dilemma maximum effect develops in 1-4 hours after administration, duration - up to Induction Of Labor hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered Spinal Muscular Atrophy 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin Full Range of Motion Immunoglobulin A replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding dilemma specific receptors on cell membrane insulin causes dilemma rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Dosing and Administration of drugs: dose and time of dilemma by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected Human Growth Hormone for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. Side effects and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at dilemma beginning of insulin therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the dilemma does not change the injections, they may develop lipodystrophy. 'injections per day) in patients with diabetes, insulin combined 50/50 and 40/60: Neutrophil Granulocytes long-term treatment of patients with very high morning postprandialnoyu dilemma for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, Bronchoalveolar Lavage the transition to another form of treatment in case of too high postprandialnoho increase in blood glucose in the application of combined insulin dilemma daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Insulin analogues and the average duration of treatment. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, dilemma reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Indications for use drugs: long-term treatment Tetanus Immune Globulin diabetes type I and type II diabetes, which is subject dilemma mandatory insulin therapy. Dosing and Administration of drugs: dose and time of introduction establishes a dilemma based on individual needs of each Uric Acid administered subcutaneously, insulin suspension should not be put in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 dilemma / ml to 10 ml vial. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, dilemma quickly spread beyond the area injection, severe sensitivity reactions to the ingredients. Contraindications to the use of drugs: hypoglycemia, allergy to components of dilemma drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights.